PT-141 (Bremelanotide)

PT-141, also known as bremelanotide, is a peptide that acts on pathways associated with sexual desire and response. It may be considered in certain men’s or women’s sexual-health treatment plans based on individual needs and a licensed provider’s medical assessment.

This option includes a provider evaluation for patients seeking compounded PT-141. Choose a 4-week or 12-week vial based on the treatment plan and your provider’s recommendation.

A licensed provider reviews your medical history, current medications, questionnaire responses, and relevant risk factors to determine whether treatment may be appropriate. Additional information or testing may be required before a prescribing decision is made.

If approved, the medication is compounded by a qualified pharmacy and shipped directly to the patient. The prescribed dose, administration instructions, and frequency of use are determined by the provider and may vary by patient.

Completing an evaluation or purchasing this service does not guarantee that medication will be prescribed. Treatment is available by prescription only and is subject to provider discretion, pharmacy requirements, state regulations, and product availability.